Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

Yasho Industries Ltd

YASHO
Speciality Chemicals

Yasho Industries Ltd's earnings have outrun its stock. EPS grew +313.2% in a year against a +137.1% price move.

The sharpest disagreement: annual EPS moved +313.2% against a +137.1% price move — the market has not yet caught up with the delivery.

The price is in a confirmed uptrend (16 weeks in) while the P/E sits at the 67th percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +800.0% year on year, and 225% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Turning around
fundamental trajectory, 12 quarters
Price
₹4,192
+137.1% 1Y
P/E
87.6×
67th pctile
of its own 5-year range
Revenue (Jun 26)
₹308 Cr
+54.8% YoY
Profit (Jun 26)
₹36.0 Cr
+800.0% YoY
Operating margin
24.0%
+7.0 pp YoY
ROCE
9%
FY26
ROIC
9.6%
vs WACC 12.0% → −2.4 pp
Cash conversion
225%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Yasho Industries Ltd trades at ₹4,192, in a confirmed uptrend and 16 weeks into that stage. That is +59.6% against its own 200-day average. It sits at 93% of a 52-week range of ₹1,204 to ₹4,401. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 31 straight weeks.

Today the stock is in a confirmed uptrend — week 16 of stage 2, confirmed. At ₹4,192 it trades +59.6% versus its 200-day average and sits at 93% of its 52-week range (₹1,204–₹4,401).

Sep 26: ₹4,192 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+59.6% versus the 200-day line, week 16 of stage 2
Price50-day avg200-day avg
S2S2S4S4S2₹4,656₹3,729₹2,802₹1,875₹948₹4,192₹2,626Sep 23Jun 24Mar 25Jan 26Sep 26
S2S2S4S4S2₹4,656₹3,729₹2,802₹1,875₹948₹4,192₹2,626Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2018 Each cell is one week from 2018 to now (416 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Apr 18Sep 26

Against the market, two honest reads. Cumulative: over the last 8.4 years the stock moved +4,054% while the NIFTY 500 moved +148% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 31 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Yasho Industries Ltd trades at 87.6× P/E, mid-range by its own standards (67th percentile). Its long-run median P/E is 45.2×, measured across 4.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 87.6× is mid-range by its own standards (67th percentile), against a long-run median of 45.2× measured over 4.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 87.6× vs a 45.2× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 4.8-year window; loss-period spikes above 136× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
mid-range by its own standards (67th percentile)
P/EMedianEPS (TTM) (quarterly)
144.6×₹65.7111.9×₹49.379.2×₹32.946.4×₹16.413.7×₹0.0×87.60×₹48Nov 21Feb 23Apr 24Jul 25Sep 26
144.6×₹65.7111.9×₹49.379.2×₹32.946.4×₹16.413.7×₹0.0×87.60×₹48Nov 21Apr 24Sep 26
P/E
87.6×
67th percentile of 5y
PEG
n/m
not derivable — 3-year earnings growth unavailable

Why the multiple sits where it does: over the past year annual EPS moved +313.2% against a +137.1% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the +45.4%/yr price move, ~+19.4%/yr came from earnings growth and ~+26.0 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Turning around

Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Yasho Industries Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −71.4% at the trough to +375.0%, a 4-quarter improving streak, ROCE holding at 11.8%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +22.8% in FY26, profit +316.7% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
77%331%53%218%30%105%5.7%−8.1%−18%−121%%%22.8%300%FY21FY23FY26
77%331%53%218%30%105%5.7%−8.1%−18%−121%%%22.8%300%FY21FY23FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit accelerating
RevenueProfitEPS
38%331%23%218%7.9%105%−7.2%−8.0%−22%−121%%%34.1%300%300%Sep 23Dec 24Jun 26
38%331%23%218%7.9%105%−7.2%−8.0%−22%−121%%%34.1%300%300%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
21%18%15%12%8.5%%11.8%Sep 23Mar 24Dec 24Sep 25Jun 26
21%18%15%12%8.5%%11.8%Sep 23Dec 24Jun 26
Revenue growth
Rising
latest +34.1% · span −18.2% to +34.1%
Profit growth
Recovering
latest +375.0% · span −89.8% to +375.0%
EPS growth
Recovering
latest +364.8% · span −89.9% to +364.8%
ROCE
Stuck low
latest 11.8% · span 9.4%–20.6%

Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+22.8%+7.3%+18.2%
Profit+316.7%−28.4%+3.5%
EPS+313.2%−29.4%+1.2%
Share price+137.1%+32.9%+45.4%
Revenue YoY (Jun 26)
+54.8%
latest quarter vs a year ago
Profit YoY (Jun 26)
+800.0%
latest quarter vs a year ago
Revenue 10y
18.2%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

62.9/100 — rank 5 of 28 in Speciality Chemicals · 87% evidence confidence

Yasho Industries Ltd scores 62.9 out of 100 against the 28 companies it is compared with in Speciality Chemicals, ranking 5. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 29.3 + 8.6 + 12 + 13 = 62.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Yasho Industries Ltd reported ₹308 Cr of revenue in the Jun 26 quarter, +54.8% year on year. That is the 10th straight quarter of year-on-year growth. Over 5 years it has compounded at 18.2% a year. The last full year, FY26, came in at ₹830 Cr. The last four reported quarters add to ₹939 Cr.

FY26 revenue came in at ₹830 Cr (+22.8% on the year), capping 5 years at 18.2% compound. The latest quarter (Jun 26) printed ₹308 Cr, +54.8% year on year — the 10th consecutive quarter of year-over-year growth.

FY26 revenue ₹830 Cr (+22.8% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 6-year window. A bar is red when it is lower than the year before.
18.2% a year over 5 years
RevenueYoY growth
89677%67253%44830%2245.7%0−18%₹ Cr%₹83022.8%FY21FY23FY26
89677%67253%44830%2245.7%0−18%₹ Cr%₹83022.8%FY21FY23FY26
Jun 26: ₹308 Cr (+54.8% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
10th straight quarter of growth
Revenue (quarterly)YoY growth
33361%24938%16614%83−9.7%0−33%₹ Cr%₹30854.8%Sep 23Dec 24Jun 26
33361%24938%16614%83−9.7%0−33%₹ Cr%₹30854.8%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +33.3% growth against the decade's 18.2% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +34.1% over the last 4 quarters against +23.4%/yr over the last 8 — accelerating; TTM profit +375.0% vs +16.5%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Yasho Industries Ltd's operating margin is 24.0% in the Jun 26 quarter, +7.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 6 fiscal years the operating margin has ranged 14.0% to 17.0%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 24.0%, +7.0 pp against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged 14.0%–17.0%, and FY26's 17.0% is the top of that band — a record year.

Why the margin moved: operating margin went +6.9 pp year on year while gross margin went +1.6 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY26: 17.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 6-year window.
the widest a 14.0–17.0% band over 6 years
operating marginYoY change (pp)
17.2%2.2%16.4%1.6%15.5%1.0%14.6%0.4%13.8%−0.2%%%17%0%FY21FY23FY26
17.2%2.2%16.4%1.6%15.5%1.0%14.6%0.4%13.8%−0.2%%%17%0%FY21FY23FY26
Jun 26: 24.0% operating margin (+7.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
25%7.9%22%4.7%19%1.5%15%−1.7%12%−4.9%%%24%7%Sep 23Dec 24Jun 26
25%7.9%22%4.7%19%1.5%15%−1.7%12%−4.9%%%24%7%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Yasho Industries Ltd earned ₹36.0 Cr of net profit in the Jun 26 quarter, +800.0% year on year. It is the 2nd consecutive quarter of growth. Full-year FY26 profit was ₹25.0 Cr. The 5-year compound rate is 3.5%. That is 11.7% of the quarter's revenue. The same quarter a year earlier earned ₹4.0 Cr.

Jun 26 profit was ₹36.0 Cr, +800.0% year on year — the 2nd consecutive quarter of growth. On the full year, FY26 printed ₹25.0 Cr (+316.7%), and the 5-year compound rate is 3.5%.

FY26 profit ₹25.0 Cr (+316.7% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 6-year window. A bar is red when it is lower than the year before.
3.5% a year over 5 years
Net profitYoY growth
73349%55231%37114%180.0%0−122%₹ Cr%₹25316.7%FY21FY23FY26
73349%55231%37114%180.0%0−122%₹ Cr%₹25316.7%FY21FY23FY26
Jun 26: ₹36.0 Cr (+800.0% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
2nd straight quarter of growth
Net profit (quarterly)YoY growth
39873%28608%17343%678%−5−186%₹ Cr%₹36800%Sep 23Dec 24Jun 26
39873%28608%17343%678%−5−186%₹ Cr%₹36800%Sep 23Dec 24Jun 26

Why profit moved: revenue contributed +54.8% and the margin +7.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.

Pace comparison, last four quarters: profit +321.7% vs revenue +33.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 225% of Yasho Industries Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹151 Cr of operating cash against ₹25.0 Cr of profit. After ₹74.0 Cr of capital spending, ₹77.0 Cr was left as free cash.

FY26: operating cash of ₹151 Cr against reported profit of ₹25.0 Cr, leaving free cash of ₹77.0 Cr after ₹74.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 225% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹151 Cr vs profit ₹25.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 6-year window, annual resolution. FY24 reflects an acquisition year — point shown clipped.
225% of 3-year profit arrived as cash
Operating cashNet profitFree cash
175890−84−170₹ Cr₹151₹25₹77FY21FY23FY26
175890−84−170₹ Cr₹151₹25₹77FY21FY23FY26
FY26: CFO = 604% of profit (three-year rate 225%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash; outlier years shown pinned.
Conversion100%
379%94%−192%−477%−762%%300%FY21FY23FY26
379%94%−192%−477%−762%%300%FY21FY23FY26

Why conversion sits at 225%: the cash cycle stretched 75 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 3.8× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Yasho Industries Ltd's cash conversion cycle runs 201 days in FY26, up from 126 days in FY21. Capital spending ran ₹464 Cr over the last 3 years. At FY26 sales of ₹830 Cr each day of that cycle holds about ₹2.3 Cr, so roughly ₹457 Cr sits inside the business at any moment.

FY26: debtors at 80 days, inventory at 186 days — roughly 6.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 201 days, looser than FY21's 126.

The full loop: cash goes out to suppliers and production on day 0; stock waits 186 days to sell; customers pay about 80 days after that; and suppliers themselves are paid at 65 days — netting out to the 201-day cycle.

In money terms: at FY26 sales of ₹830 Cr, each day of the cycle holds about ₹2.3 Cr — so the 201-day loop keeps roughly ₹457 Cr sitting inside the business at any moment.

FY26: a 201-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 6-year window.
+75 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
2762141529028days201d186d80d65dFY21FY22FY23FY24FY26
2762141529028days201d186d80d65dFY21FY23FY26

On the investment side: capital spending of ₹464 Cr over the last 3 fiscal years against ₹121 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹10.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹74.0 Cr, work-in-progress ₹10.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
4983732491240₹ Cr₹74₹10FY22FY23FY24FY25FY26
4983732491240₹ Cr₹74₹10FY22FY24FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Yasho Industries Ltd earns a ROCE of 9% in FY26. That is up from a trough of 7% in FY25. Return on invested capital clears the cost of that capital by −2.4 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 3.0% net margin on 0.72× asset turns.

FY26 ROCE is 9%, recovered from a FY25 trough of 7% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 3.0% net margin × 0.72× asset turns × 2.60× balance-sheet leverage ≈ 5.6% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 9.6% − 12.0% = a −2.4 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 9% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY25's 7%
ROCEROIC (annual)WACC
31%24%17%10.0%3.0%%9%6.6%FY22FY24FY26
31%24%17%10.0%3.0%%9%6.6%FY22FY24FY26
Q4 FY26: ROCE 11.3% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
19%15%12%8.5%5.0%%11.3%6.2%Q1 FY24Q2 FY25Q4 FY26
19%15%12%8.5%5.0%%11.3%6.2%Q1 FY24Q2 FY25Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Yasho Industries Ltd carries total debt of ₹558 Cr against shareholder equity of ₹444 Cr as of Mar 26, a debt-to-equity of 1.26. On the annual view that ratio went from 1.03 in FY22 to 1.26 in FY26. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of ₹558 Cr against shareholder equity of ₹444 Cr — a debt-to-equity of 1.26. On the annual view, debt-to-equity went from 1.03 (FY22) to 1.26 (FY26). Read the returns on this page with that leverage in mind.

FY26: debt ₹558 Cr at 1.26× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
6302.0×4721.8×3151.5×1571.2×01.0×₹ Cr×₹5581.26×FY22FY24FY26
6302.0×4721.8×3151.5×1571.2×01.0×₹ Cr×₹5581.26×FY22FY24FY26
Mar 26: debt ₹558 Cr, debt-to-equity 1.26 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
6852.2×5141.9×3421.7×1711.4×01.2×₹ Cr×₹5581.26×Jun 23Sep 24Mar 26
6852.2×5141.9×3421.7×1711.4×01.2×₹ Cr×₹5581.26×Jun 23Sep 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions added 4.8 points of Yasho Industries Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 5.7% of the company. Promoters moved −4.0 points over the same window, to 67.9%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: +4.8 points over 8 quarters to 5.7%; Promoters: −4.0 points over 8 quarters to 67.9%; Domestic institutions: +2.2 points over 8 quarters to 2.2%.

Why the register moved: foreign institutions drove it (+4.8 points), absorbed on the other side by promoters (−4.0 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters −4.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
78%57%36%15%−5.8%%67.9%5.7%2.0%24.4%Mar 24Mar 25Mar 26
78%57%36%15%−5.8%%67.9%5.7%2.0%24.4%Mar 24Mar 25Mar 26
Foreign institutions added 4.8 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
78%57%36%15%−5.8%%67.9%5.7%2.2%24.1%Jun 23Dec 24Jun 26
78%57%36%15%−5.8%%67.9%5.7%2.2%24.1%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Yasho Industries Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Speciality Chemicals
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Panama Petrochem LtdPANAMAPET 74.9/100Favorable setup100% evidence LEADER 28.1/35 Revenue 45.9% · PAT 100% · OPM change 14 pp 100% evidence 14.9/25 ROCE 19.2% · OPM 22% 100% evidence 15.4/20 P/E 6.1× · PEG 0.55 100% evidence 16.5/20 RS sector 18.7% · RS bench 46.9% · 1Y 64.6%12 of 12 weeks ahead 100% evidence
Exact sum: 28.1 + 14.9 + 15.4 + 16.5 = 74.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Sunshield Chemicals Ltd530845 69.8/100Favorable setup76% evidence FADING 28.0/35 Revenue 12.9% · PAT 100% · OPM change 5 pp 95% evidence 16.6/25 ROCE 19.9% · OPM 16% 76% evidence 11.3/20 P/E 29.1× · PEG — 50% evidence 13.9/20 RS sector 2.3% · RS bench 24.5% · 1Y 16.2%10 of 11 weeks ahead 70% evidence
Exact sum: 28 + 16.6 + 11.3 + 13.9 = 69.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3Vikram Thermo (India) Ltd530477 65.5/100Favorable setup67% evidence BREAKING OUT 25.5/35 Revenue 16.9% · PAT 41.9% · OPM change 8 pp 95% evidence 19.8/25 ROCE 36.2% · OPM 48% 76% evidence 7.9/20 P/E 24.3× · PEG — 50% evidence 12.3/20 RS sector — · RS bench 83.6% · 1Y —10 of 10 weeks ahead 25% evidence
Exact sum: 25.5 + 19.8 + 7.9 + 12.3 = 65.5 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
4Black Rose Industries LtdBLACKROSE 64.2/100Mixed-positive evidence72% evidence BREAKING OUT 22.0/35 Revenue 8.6% · PAT 28.6% · OPM change 6 pp 95% evidence 17.1/25 ROCE 18.7% · OPM 16% 95% evidence 14.5/20 P/E 19.2× · PEG — 50% evidence 10.6/20 RS sector — · RS bench 11.6% · 1Y —4 of 6 weeks ahead 25% evidence
Exact sum: 22 + 17.1 + 14.5 + 10.6 = 64.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Yasho Industries Ltdthis pageYASHO 62.9/100Mixed-positive evidence87% evidence BREAKING OUT 29.3/35 Revenue 34.1% · PAT 100% · OPM change 7 pp 100% evidence 8.6/25 ROCE 8.9% · OPM 24% 100% evidence 12.0/20 P/E 87.6× · PEG 1.15 65% evidence 13.0/20 RS sector -2.4% · RS bench 102% · 1Y 131.1%11 of 11 weeks ahead 70% evidence
Exact sum: 29.3 + 8.6 + 12 + 13 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Privi Speciality Chemicals LtdPRIVISCL 59.9/100Mixed-positive evidence75% evidence FADING 25.0/35 Revenue 21.6% · PAT 62.1% · OPM change -1 pp 95% evidence 17.9/25 ROCE 22.3% · OPM 23% 76% evidence 9.5/20 P/E 39.7× · PEG — 15% evidence 7.5/20 RS sector -8.1% · RS bench 15.3% · 1Y 55.8%7 of 12 weeks ahead 100% evidence
Exact sum: 25 + 17.9 + 9.5 + 7.5 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Aether Industries LtdAETHER 58.4/100Mixed-positive evidence100% evidence BREAKING OUT 24.4/35 Revenue 34.4% · PAT 34.3% · OPM change -1 pp 100% evidence 10.7/25 ROCE 11.9% · OPM 31% 100% evidence 4.2/20 P/E 92.6× · PEG 8.9 100% evidence 19.1/20 RS sector 23.6% · RS bench 53.6% · 1Y 125.8%11 of 12 weeks ahead 100% evidence
Exact sum: 24.4 + 10.7 + 4.2 + 19.1 = 58.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8DMCC Speciality Chemicals LtdDMCC 56.8/100Mixed-positive evidence80% evidence TURNING 24.4/35 Revenue 49.7% · PAT 42.9% · OPM change 0 pp 95% evidence 11.0/25 ROCE 14.8% · OPM 13% 95% evidence 11.4/20 P/E 17.9× · PEG — 15% evidence 10.0/20 RS sector -12.3% · RS bench 10% · 1Y -6.5%6 of 12 weeks ahead 100% evidence
Exact sum: 24.4 + 11 + 11.4 + 10 = 56.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Pidilite Industries LtdPIDILITIND 56.7/100Mixed-positive evidence100% evidence FADING 22.6/35 Revenue 14.1% · PAT 21.5% · OPM change 1 pp 100% evidence 20.6/25 ROCE 31% · OPM 26% 100% evidence 7.9/20 P/E 60.2× · PEG 3.8 100% evidence 5.6/20 RS sector -15.4% · RS bench 6.4% · 1Y 1.3%11 of 12 weeks ahead 100% evidence
Exact sum: 22.6 + 20.6 + 7.9 + 5.6 = 56.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Tatva Chintan Pharma Chem LtdTATVA 56.0/100Mixed-positive evidence93% evidence BREAKING OUT 30.4/35 Revenue 41.1% · PAT 100% · OPM change 4 pp 100% evidence 6.5/25 ROCE 7.2% · OPM 19% 100% evidence 4.7/20 P/E 71.8× · PEG 5.63 65% evidence 14.4/20 RS sector -1.5% · RS bench 23.3% · 1Y 61.3%11 of 12 weeks ahead 100% evidence
Exact sum: 30.4 + 6.5 + 4.7 + 14.4 = 56 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Fineotex Chemical LtdFCL 54.0/100Mixed-positive evidence100% evidence LEADER 18.4/35 Revenue 91.5% · PAT 41% · OPM change -2 pp 100% evidence 12.7/25 ROCE 18.3% · OPM 16% 100% evidence 3.0/20 P/E 54.9× · PEG 4.19 100% evidence 19.9/20 RS sector 58% · RS bench 94.1% · 1Y 143.6%12 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 12.7 + 3 + 19.9 = 54 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Aarti Industries LtdAARTIIND 53.5/100Mixed-positive evidence100% evidence BREAKING OUT 27.7/35 Revenue 27% · PAT 100% · OPM change 3 pp 100% evidence 8.3/25 ROCE 6.9% · OPM 16% 100% evidence 9.0/20 P/E 34.2× · PEG 2.05 100% evidence 8.5/20 RS sector -8.2% · RS bench 15.1% · 1Y 30.8%8 of 12 weeks ahead 100% evidence
Exact sum: 27.7 + 8.3 + 9 + 8.5 = 53.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Kronox Lab Sciences LtdKRONOX 53.3/100Mixed-positive evidence65% evidence BREAKING OUT 9.4/35 Revenue 6.1% · PAT 11.6% · OPM change -1.1 pp 95% evidence 21.6/25 ROCE 36% · OPM 31.7% 95% evidence 10.8/20 P/E 22.8× · PEG — 15% evidence 11.5/20 RS sector — · RS bench 24.8% · 1Y —5 of 5 weeks ahead 25% evidence
Exact sum: 9.4 + 21.6 + 10.8 + 11.5 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Chemcon Speciality Chemicals LtdCHEMCON 51.1/100Mixed-positive evidence81% evidence TURNING 21.0/35 Revenue 16.7% · PAT 12% · OPM change 8 pp 95% evidence 10.7/25 ROCE 6.3% · OPM 23% 95% evidence 12.1/20 P/E 28.2× · PEG — 50% evidence 7.3/20 RS sector -21.7% · RS bench 13.7% · 1Y 4.3%6 of 10 weeks ahead 70% evidence
Exact sum: 21 + 10.7 + 12.1 + 7.3 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Vishnu Chemicals LtdVISHNU 47.7/100Mixed-negative evidence100% evidence BREAKING OUT 15.5/35 Revenue 16.5% · PAT 17.2% · OPM change -1 pp 100% evidence 11.3/25 ROCE 16.4% · OPM 15% 100% evidence 5.6/20 P/E 32.1× · PEG 2.82 100% evidence 15.3/20 RS sector 4.7% · RS bench 31.2% · 1Y 48.7%7 of 12 weeks ahead 100% evidence
Exact sum: 15.5 + 11.3 + 5.6 + 15.3 = 47.7 · Decision use: Price leads the evidence: RS versus the benchmark is 31.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
16Galaxy Surfactants LtdGALAXYSURF 47.3/100Mixed-negative evidence94% evidence BREAKING OUT 19.5/35 Revenue 27% · PAT 15.7% · OPM change 4 pp 100% evidence 9.4/25 ROCE 13.5% · OPM 14% 100% evidence 9.6/20 P/E 21.3× · PEG 4.39 100% evidence 8.8/20 RS sector -12.1% · RS bench 11.3% · 1Y -6.7%8 of 10 weeks ahead 70% evidence
Exact sum: 19.5 + 9.4 + 9.6 + 8.8 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Alkyl Amines Chemicals LtdALKYLAMINE 46.8/100Mixed-negative evidence100% evidence FADING 18.4/35 Revenue 5.1% · PAT 21% · OPM change 6 pp 100% evidence 15.6/25 ROCE 16.6% · OPM 25% 100% evidence 5.6/20 P/E 42.4× · PEG 5.37 100% evidence 7.2/20 RS sector -10.8% · RS bench 11.6% · 1Y -9.9%11 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 15.6 + 5.6 + 7.2 = 46.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Vinati Organics LtdVINATIORGA 44.4/100Mixed-negative evidence82% evidence TURNING 11.2/35 Revenue 5.1% · PAT 5.7% · OPM change -5 pp 95% evidence 17.5/25 ROCE 19.8% · OPM 24% 76% evidence 13.4/20 P/E 29.9× · PEG — 50% evidence 2.3/20 RS sector -28.7% · RS bench -9.8% · 1Y -23.9%0 of 12 weeks ahead 100% evidence
Exact sum: 11.2 + 17.5 + 13.4 + 2.3 = 44.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
19Amal LtdAMAL 43.0/100Mixed-negative evidence69% evidence 8.0/35 Revenue 79% · PAT -23.1% · OPM change -7 pp 95% evidence 16.4/25 ROCE 26% · OPM 18% 76% evidence 10.0/20 P/E 30.7× · PEG — 15% evidence 8.6/20 RS sector -18.2% · RS bench 15.4% · 1Y -20%0 of 12 weeks ahead 70% evidence
Exact sum: 8 + 16.4 + 10 + 8.6 = 43 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Platinum Industries LtdPLATIND 42.5/100Mixed-negative evidence74% evidence BASING 12.8/35 Revenue 9.6% · PAT 6.5% · OPM change -1 pp 95% evidence 12.3/25 ROCE 15.7% · OPM 12% 95% evidence 10.6/20 P/E 23.9× · PEG — 15% evidence 6.8/20 RS sector -10.6% · RS bench -6.1% · 1Y -22.8%0 of 10 weeks ahead 70% evidence
Exact sum: 12.8 + 12.3 + 10.6 + 6.8 = 42.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Grauer & Weil (India) LtdGRAUWEIL 41.5/100Mixed-negative evidence100% evidence TURNING 10.4/35 Revenue 10.1% · PAT 6.6% · OPM change -5 pp 100% evidence 16.1/25 ROCE 20.6% · OPM 16% 100% evidence 8.2/20 P/E 21.4× · PEG 4.01 100% evidence 6.8/20 RS sector -17.8% · RS bench 3.4% · 1Y -18.5%6 of 12 weeks ahead 100% evidence
Exact sum: 10.4 + 16.1 + 8.2 + 6.8 = 41.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Anupam Rasayan India LtdANURAS 41.5/100Mixed-negative evidence82% evidence ASLEEP 20.0/35 Revenue 51.7% · PAT 14.8% · OPM change -1 pp 95% evidence 10.5/25 ROCE 7.4% · OPM 25% 76% evidence 8.3/20 P/E 79.5× · PEG — 50% evidence 2.7/20 RS sector -21.7% · RS bench -1% · 1Y 9.8%0 of 12 weeks ahead 100% evidence
Exact sum: 20 + 10.5 + 8.3 + 2.7 = 41.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Neogen Chemicals LtdNEOGEN 40.5/100Mixed-negative evidence90% evidence LEADER 14.7/35 Revenue 18.1% · PAT 6.1% · OPM change 2 pp 100% evidence 6.7/25 ROCE 6.5% · OPM 19% 100% evidence 5.2/20 P/E 183× · PEG — 50% evidence 13.9/20 RS sector 22.9% · RS bench 52% · 1Y 59.6%12 of 12 weeks ahead 100% evidence
Exact sum: 14.7 + 6.7 + 5.2 + 13.9 = 40.5 · Decision use: Price leads the evidence: RS versus the benchmark is 52%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
24Paushak LtdPAUSHAKLTD 37.0/100Mixed-negative evidence81% evidence BREAKING OUT 11.9/35 Revenue 15.4% · PAT -15.7% · OPM change -1 pp 95% evidence 10.0/25 ROCE 8.3% · OPM 31% 95% evidence 7.5/20 P/E 42.4× · PEG — 50% evidence 7.6/20 RS sector -27.5% · RS bench 28% · 1Y -4.6%11 of 11 weeks ahead 70% evidence
Exact sum: 11.9 + 10 + 7.5 + 7.6 = 37 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Clean Science & Technology LtdCLEAN 36.3/100Mixed-negative evidence94% evidence BREAKING OUT 4.5/35 Revenue -0.4% · PAT -13.8% · OPM change -5 pp 100% evidence 18.5/25 ROCE 20.7% · OPM 36% 100% evidence 7.8/20 P/E 38.4× · PEG 6.24 100% evidence 5.5/20 RS sector -24.4% · RS bench 1.4% · 1Y -29.2%2 of 10 weeks ahead 70% evidence
Exact sum: 4.5 + 18.5 + 7.8 + 5.5 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Amines & Plasticizers LtdAMNPLST 35.5/100Mixed-negative evidence81% evidence ASLEEP 7.8/35 Revenue -12.4% · PAT -3% · OPM change 0.7 pp 95% evidence 14.0/25 ROCE 16.7% · OPM 9.9% 95% evidence 8.8/20 P/E 23.6× · PEG — 50% evidence 4.9/20 RS sector -19.4% · RS bench -9.2% · 1Y -27.6%5 of 10 weeks ahead 70% evidence
Exact sum: 7.8 + 14 + 8.8 + 4.9 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Transpek Industry LtdTRANSPEK 34.5/100Adverse evidence81% evidence TURNING 6.4/35 Revenue -5.2% · PAT -29.1% · OPM change -2.3 pp 95% evidence 9.1/25 ROCE 8.4% · OPM 13.3% 95% evidence 11.3/20 P/E 19.3× · PEG — 50% evidence 7.7/20 RS sector -19.7% · RS bench 11.7% · 1Y -4.7%4 of 10 weeks ahead 70% evidence
Exact sum: 6.4 + 9.1 + 11.3 + 7.7 = 34.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Thirumalai Chemicals LtdTIRUMALCHM 25.9/100Adverse evidence69% evidence BASING 13.1/35 Revenue -5.8% · PAT -36.9% · OPM change 12 pp 71% evidence 1.1/25 ROCE -3.1% · OPM 6% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 1.7/20 RS sector -39.8% · RS bench -23.6% · 1Y -49%0 of 12 weeks ahead 100% evidence
Exact sum: 13.1 + 1.1 + 10 + 1.7 = 25.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Yasho Industries Ltd's share price today?

Yasho Industries Ltd trades at ₹4,192, +137.1% over the past year. The company is valued at ₹5,049 Cr. The stock sits at 93% of its 52-week range of ₹1,204–₹4,401, +59.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 16 weeks in. — as of 11 September 2026.

What were Yasho Industries Ltd's latest quarterly results?

Yasho Industries Ltd reported revenue of ₹308 Cr and net profit of ₹36.0 Cr for the Jun 26 quarter. Revenue rose 54.8% and profit rose 800.0% year on year. Earnings per share were ₹29.90. The operating margin was 24.0%, 7.0 pp higher than a year earlier. — as of 11 September 2026.

What is Yasho Industries Ltd's revenue?

Yasho Industries Ltd reported revenue of ₹308 Cr in the Jun 26 quarter, +54.8% year on year. For the full FY26 fiscal year, revenue was ₹830 Cr (+22.8%). Over the last 5 years revenue compounded at 18.2% a year. — as of 11 September 2026.

What is Yasho Industries Ltd's profit?

Yasho Industries Ltd earned ₹36.0 Cr of net profit in the Jun 26 quarter, +800.0% year on year — the 2nd straight quarter of growth. Full-year FY26 profit was ₹25.0 Cr. The operating margin ran 24.0% in the latest quarter. — as of 11 September 2026.

What is Yasho Industries Ltd's market cap?

Yasho Industries Ltd's market capitalisation is ₹5,049 Cr at a share price of ₹4,192. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is Yasho Industries Ltd's P/E ratio?

Yasho Industries Ltd trades at a P/E of 87.6×, at the 67th percentile of its own 5-year range, against a long-run median of 45.2×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does Yasho Industries Ltd pay a dividend?

Yes — Yasho Industries Ltd's dividend payout was 2% of profit in FY26, and it recorded a payout in each of its last 6 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.

Is Yasho Industries Ltd overvalued?

On its own history, Yasho Industries Ltd looks expensive: its P/E of 87.6× sits at the 67th percentile of its 5-year range (long-run median 45.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 11 September 2026.

Is Yasho Industries Ltd growing?

Yes — Yasho Industries Ltd is growing: latest-quarter revenue +54.8% year on year, profit +800.0%, and the margin +7.0 pp at 24.0%. The 5-year compound rates are 18.2% (revenue) and 3.5% (profit). The earnings engine currently reads: improving — as of 11 September 2026.

How is Yasho Industries Ltd performing?

Yasho Industries Ltd is in a confirmed uptrend, 16 weeks in. Its latest quarter's revenue rose 54.8% and profit rose 800.0% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 31 weeks. This describes what the data did, not a rating. — as of 11 September 2026.

What stage is Yasho Industries Ltd in?

Turning around — profit growth swung from −71.4% at the trough to +375.0%, a 4-quarter improving streak, ROCE holding at 11.8%. The read comes from the last 12 quarters of growth (revenue growth +34.1% latest, profit growth +375.0% latest, eps growth +364.8% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.

Is Yasho Industries Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 16 of stage 2), trading +59.6% versus its 200-day average and at 93% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is Yasho Industries Ltd beating the market?

On recent form, yes — Yasho Industries Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 31 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 8.4 years the stock moved +4,054% against the NIFTY 500's +148% — ahead of the index over the full window. — as of 11 September 2026.

Will Yasho Industries Ltd's share price go up?

This page publishes no price forecast for Yasho Industries Ltd. What it measures instead: the share price is ₹4,192, the price is in a confirmed uptrend 16 weeks in. Its P/E of 87.6× sits at the 67th percentile of its own 5-year range. — as of 11 September 2026.

Who owns Yasho Industries Ltd?

Promoters hold 67.9% of Yasho Industries Ltd, foreign institutions 5.7%, domestic institutions 2.2% and the public 24.1% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 4.8 points over 8 quarters. — as of 11 September 2026.

Does Yasho Industries Ltd have too much debt?

It carries real leverage — Yasho Industries Ltd's debt-to-equity is 1.26, and operating profit covers the interest bill 3×. FY26 borrowings were ₹558 Cr against equity of ₹444 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.

What is Yasho Industries Ltd's capex?

Yasho Industries Ltd spent ₹464 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹74.0 Cr, with ₹10.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.

What is Yasho Industries Ltd's cash flow?

Yasho Industries Ltd generated ₹151 Cr of operating cash flow in FY26 and ₹77.0 Cr of free cash flow after ₹74.0 Cr of capital spending. Reported profit that year was ₹25.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.

Is Yasho Industries Ltd's profit real cash?

Yes — over the last 3 fiscal years, 225% of Yasho Industries Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹151 Cr against reported profit of ₹25.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.

Where is Yasho Industries Ltd in its business cycle?

Yasho Industries Ltd's FY26 operating margin was 17.0%, against a 6-year band of 14.0%–17.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 24.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What could break the Yasho Industries Ltd story?

The sharpest disagreement: annual EPS moved +313.2% against a +137.1% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is Yasho Industries Ltd a stock worth studying right now?

This is not investment advice. The machine read: Yasho Industries Ltd's earnings have outrun its stock. EPS grew +313.2% in a year against a +137.1% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI